ARMP
Armata Pharmaceuticals Inc
3.90$
+5.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8,500.0% | -452.2% | -1,388.9% | -80.6% | -155.9% | -5.3% | -124.7% | -103.9% | -79.8% | -160.8% | -238.4% | -118.0% | -134.4% | -118.2% | -3,891.7% | -644.7% | -2,291.7% | -3,073.8% | -2,059.2% | -4,072.7% | -7,993.0% | – | -50,264.5% | -2,219.9% | -526.9% | -589.7% | -1,047.1% | -725.8% | -525.3% | |
| – | 1,400.0% | 82.6% | 177.8% | 22.2% | 23.5% | 30.3% | 46.0% | 18.7% | 17.2% | 13.4% | 19.2% | 7.3% | 5.8% | 5.9% | 66.7% | 13.7% | 25.2% | 38.6% | 69.5% | 141.9% | 325.2% | – | 4,358.1% | 135.4% | 26.1% | 16.2% | 21.5% | 25.6% | 31.2% | |
| – | – | – | – | – | – | – | 0.4% | – | – | – | – | – | 9.3% | 8.2% | – | 1.4% | 442.2% | 473.3% | 101.7% | 767.3% | 608.7% | – | 13,777.4% | 422.2% | 64.4% | 56.4% | 20.7% | 55.9% | 53.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 254.8% | – | 15,274.2% | 446.1% | 76.3% | 70.8% | – | – | – | |
| – | 3,200.0% | 39.1% | 722.2% | 2.8% | -19.1% | -28.3% | -46.7% | -14.5% | 2.6% | -16.2% | 19.8% | -5.2% | 3.5% | 16.4% | -3,566.7% | -22.7% | 324.0% | -135.9% | -33.3% | 257.7% | -397.4% | – | -7,061.3% | -106.2% | -72.0% | 8.0% | -213.0% | -40.6% | -28.8% | |
| – | 1,300.0% | 65.2% | 77.8% | 2.8% | 27.9% | 24.5% | 23.4% | 2.9% | 2.2% | 4.2% | 9.7% | 0.8% | 5.4% | 8.5% | 91.7% | 8.0% | 31.4% | 293.9% | 44.2% | 107.3% | 50.4% | – | 422.6% | 100.1% | 29.1% | 40.1% | 179.8% | 36.3% | 11.1% | |
| – | -4,300.0% | -143.5% | 1,177.8% | -86.1% | 75.0% | -19.5% | -38.2% | -12.9% | -2.2% | -4.2% | -8.9% | -0.3% | -5.0% | -7.6% | – | 466.4% | -31.4% | -293.9% | -44.2% | -107.3% | -50.4% | – | 9,280.6% | -100.1% | -29.1% | -40.1% | -179.6% | -36.3% | -11.1% | |
| – | – | – | – | – | 5.9% | – | 5.0% | – | – | – | – | – | – | – | – | – | – | – | – | 30.8% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2,690.5% | -66.5% | 8,248.7% | – | 32,177.4% | 2,802.1% | 602.0% | 808.2% | -0.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 623.5% | – | 2,312.9% | 87.1% | 0.0% | -9.1% | 1,192.9% | 674.3% | 509.8% | |
| – | 12,700.0% | 652.2% | -55.6% | 179.2% | 114.7% | 327.6% | 91.7% | 51.8% | 142.1% | 300.1% | -43.2% | 38.0% | 238.4% | -3.0% | 2,075.0% | 143.1% | 8,308.3% | – | 2,690.5% | 2,772.7% | 7,540.0% | – | 28,951.6% | 2,820.2% | 570.4% | 799.1% | 1,192.1% | 675.6% | 522.3% | |
| – | -2,300.0% | -95.7% | -277.8% | -13.9% | 32.4% | 302.8% | -71.2% | -65.1% | 60.1% | 135.1% | -290.6% | -80.3% | 99.1% | -128.8% | -1,900.0% | -35.2% | 5,997.8% | -3,367.7% | 587.2% | -1,407.3% | -503.5% | – | -12,032.3% | 500.1% | 14.3% | 82.9% | -34.6% | -86.4% | -14.1% | |
| – | -9,800.0% | -517.4% | -1,466.7% | -83.3% | -183.8% | -29.8% | -148.1% | -106.9% | -82.0% | -165.1% | -248.2% | -118.8% | -139.7% | -126.7% | -3,983.3% | -652.7% | -2,323.1% | -3,367.7% | -2,103.4% | -4,180.0% | -8,043.5% | – | -50,687.1% | -2,320.0% | -556.1% | -629.8% | -1,226.9% | -762.1% | -536.4% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.